Participate in our study.

The CanTreatCOVID trial relies on volunteers, often referred to as participants, to help us better understand the effectiveness of medications for mild to moderate COVID-19. The study is open to Canadians (18+ years of age) who are within the first 5 days of experiencing COVID-19 symptoms.

Learn more about the study